Abstract submission deadline: TODAY! 👇🏽 Don’t miss the chance to showcase your research in cancer immunotherapy and present it as a short or flash talk. 🗓️ Registration deadline: 02 February Organised by the @helloeacr.bsky.social

EACR - European Association for Cancer Research@helloeacr.bsky.social · 9mo ago

Submit your abstract for our virtual Next Generation Immunotherapies conference for a chance to have your work featured as a Proffered Paper or in a Flash Talk presentation. Don't miss the 12 January deadline: eacr.org/conference/n...

Abstract submission deadline: Monday, 12 January! 👇🏽 Don’t miss the chance to showcase your research in cancer immunotherapy and present it as a short or flash talk. 🗓️ Registration deadline: 02 February Organised by the @helloeacr.bsky.social

EACR - European Association for Cancer Research@helloeacr.bsky.social · 9mo ago

Submit your abstract for our virtual Next Generation Immunotherapies conference for a chance to have your work featured as a Proffered Paper or in a Flash Talk presentation. Don't miss the 12 January deadline: eacr.org/conference/n...

Submit your abstract for our virtual Next Generation Immunotherapies conference for a chance to have your work featured as a Proffered Paper or in a Flash Talk presentation. Don't miss the 12 January deadline: eacr.org/conference/n...

Aquí van algunos ejemplos (incluido el tuyo 😉). Pero por subáreas, que es lo que aparece en la tabla del Ministerio. bsky.app/profile/jaes...

Jose A. Esteban@jaestebancbm.bsky.social · last yr.

Me preguntan por la financiación de distintas áreas. Son muchas... Aquí pongo de ejemplo una humanidades (Historia), una de ciencias "básicas" (Química) y una de biomedicina (Cáncer). La financiación media varía mucho, claro, pero el raquitismo relativo se mantiene... 😕

@megeblad.bsky.social once more revealing significant cancer biology - Congrats! www.nature.com/articles/s41...

Neutrophils drive vascular occlusion, tumour necrosis and metastasis - Nature

Neutrophils actively induce tumour necrosis, driving vascular occlusion, pleomorphic necrosis and metastasis.

nature.com

🔬 El grupo #CáncerdeMama de #Biogipuzkoa ha analizado la posibilidad de que existan genes que pueden utilizarse para predecir la respuesta al tratamiento endocrino previo a la cirugía en las pacientes con cáncer de mama luminal. 📝 https://f.mtr.cool/oiaoddswvc

I’m happy to share our latest work on tumour necrosis! During my time in the @megeblad.bsky.social lab, we found that tumour necrosis is not a passive phenomenon secondary to tumour growth, but an active phenomenon driven by neutrophils and NETs! Thread below: (1/13) www.nature.com/articles/s41...

Neutrophils drive vascular occlusion, tumour necrosis and metastasis - Nature

Neutrophils actively induce tumour necrosis, driving vascular occlusion, pleomorphic necrosis and metastasis.

nature.com

🚀 Discover the latest breakthroughs in cancer research! The July 2025 Highlights in Cancer Research features 10 standout papers, including insights into lung cancer progression and chemo sensitivity linked to the oestrous cycle. Read more: magazine.eacr.org/highlights-i...

A fresh virtual event spotlighting cutting-edge immunotherapies => be at the forefront of innovation. Do not miss it!

EACR - European Association for Cancer Research@helloeacr.bsky.social · last yr.

Registration and abstract submission is open for Next Generation Immunotherapies! Join us online next February to explore cutting-edge developments in immunotherapy, ranging from basic research to clinical applications. Learn more: eacr.org/conference/n...

Do not miss this beautiful work on TIM3 and immune evasion and micrometastasis just published in @cp-cancercell.bsky.social by @tceliaterrassa.bsky.social lab! Congrats my dear friend!

Toni Celià-Terrassa@tceliaterrassa.bsky.social · last yr.

We’re thrilled to share our latest publication in @cp-cancercell.bsky.social and very proud of C. Rozalén for this tour de force uncovering how TIM3⁺ breast cancer cells drive immune evasion during micrometastasis. #CancerImmunology #BreastCancer #Metastasis www.cell.com/cancer-cell/...

Congrats @emlecona.bsky.social and team! Beautiful work! Many more to come from this great lab!

Emilio Lecona@emlecona.bsky.social · last yr.

Very happy to share our recently published work on the role of VCP/p97 during DNA replication.

Extremely happy and proud to share with you all our last article in @CR_AACR on the prometastatic role of PPAR-delta in pancreatic cancer. Check it out here: aacrjournals.org/cancerres/ar...

🩷 Hoy hemos recibido a las voluntarias de #MaitetaBizi y nos han hecho entrega del cheque de 7.000€. El dinero será destinado a las líneas del grupo de #CancerdeMama de #Biogipuzkoa liderado por @mariacaffarel.bsky.social e Isabel Álvarez. 🤲 ¡Muchas gracias, seguimos investigando juntas!

A huge thank you to all participants, speakers and organisers of this week's Early Career Researchers' Conference! Always a favourite of ours in the EACR virtual conference calendar 😊

Are you looking to start your #lab in a fantastic scientific 🧪environment, with great colleagues, and in a spectacular place to live? Then check out our open #junior #faculty position at the Department of Oncology, University of Lausanne, Switzerland: www.unil.ch/dof/en/home/... ⏰ Deadline 27 June

Very grateful as well for the amazing science and fun with friends from @biogipuzkoa.bsky.social @aseica.bsky.social @helloeacr.bsky.social #ECRcouncil

Maria M Caffarel@mariacaffarel.bsky.social · last yr.

On my way home after a great #EACR2025 conference in Lisbon. Thanks @helloeacr.bsky.social for the oppurtunity to present our work from @biogipuzkoa.bsky.social and for the Travel Fellowship to @peioazcoaga.bsky.social !

On my way home after a great #EACR2025 conference in Lisbon. Thanks @helloeacr.bsky.social for the oppurtunity to present our work from @biogipuzkoa.bsky.social and for the Travel Fellowship to @peioazcoaga.bsky.social !

It’s hard to believe #EACR2025 is almost over! Huge thanks from the EACR Congress team to everyone who made it so special. And to those following along from home - we hope to welcome you in person next year!

So grateful for the opportunity to present our project from amazing Caffarel Lab @mariacaffarel.bsky.social in such a great #EACR2025 Congress @helloeacr.bsky.social 🤩👏🔝

Great talk by #MatheusdosSantosDias at the @helloeacr.bsky.social cancer researchers to watch symposium! Good luck with your new adventure as PI at the #princesMaximaCenter! 🍀

@helloeacr.bsky.social #EACR2025 Cancer Researcher s to Watch Event is on!!!! by @mariacaffarel.bsky.social 👏👏

Amazing talk by Prof María Caffarel @mariacaffarel.bsky.social at the @helloeacr.bsky.social #EACR2025 Beautiful work!! cytokines rock 👏👏👏🤩

Congrats @peioazcoaga.bsky.social 👏🏻👏🏻👏🏻

Peio Azcoaga@peioazcoaga.bsky.social · last yr.

So happy to be selected as a congress correspondent 😄 and to be part of the @helloeacr.bsky.social community!! Many thanks!! Amazing #EACR2025 Congress ahead, really looking forward ;) 👏🙌

If interested in cancer-associated fibroblasts, please apply! Great science and great PI! 👇🏽

Fernando Calvo@calvolab.bsky.social · last yr.

JOB ALERT!! 🧪 We are offering a postdoc position within our “antiCAFing” ERC-CoG project to investigate the interplay CAFs:endothelial cells and its impact in aberrant vascularization in tumors. More details below 👇. Please spread the word.

JOB ALERT!! 🧪 We are offering a postdoc position within our “antiCAFing” ERC-CoG project to investigate the interplay CAFs:endothelial cells and its impact in aberrant vascularization in tumors. More details below 👇. Please spread the word.

Thank you @idibell.bsky.social and @rrodriguezbarrueco.bsky.social for the invitation! It has been a great day of scientific discussions and friendship. @elisaespinet.bsky.social @txellrovira.bsky.social Looking forward to exciting new collaborations 🧬🔬💊

Now is the turn of #AnaJanic describing new therapeutic strategies to promote immunogenicity in the @helloeacr.bsky.social conference Defence is the best attack. Congrats Ana! Beautiful work!

Are you attending the 2025 'Defence is the Best Attack: Immuno-Oncology Breakthroughs' conference in Barcelona? So is our editor Lise Roth! Talk to her if you are looking for a home for your paper or about scientific publishing @embopress.org @helloeacr.bsky.social

📭 Are you attending 'Defence is the Best Attack: Immuno-Oncology Breakthroughs‘ and are interested into our call for papers? Check Details here ➡️ febs.onlinelibrary.wiley.com/hub/journal/... or ➡️ talk to our editor Ruzhica Bogeska on site. @helloeacr.bsky.social

Great talk by @casanova-acebes.bsky.social at the @helloeacr.bsky.social conference #Defenseisthebestattack about circadian modulation of myeloid cells and CAFs in cancer. Congrats! Beautiful work